A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins D Corti, J Voss, SJ Gamblin, G Codoni, A Macagno, D Jarrossay, ... Science 333 (6044), 850-856, 2011 | 1342 | 2011 |
Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques NB Mercado, R Zahn, F Wegmann, C Loos, A Chandrashekar, J Yu, J Liu, ... Nature 586 (7830), 583-588, 2020 | 963 | 2020 |
Analysis of memory B cell responses and isolation of novel monoclonal antibodies with neutralizing breadth from HIV-1-infected individuals D Corti, JPM Langedijk, A Hinz, MS Seaman, F Vanzetta, ... PloS one 5 (1), e8805, 2010 | 521 | 2010 |
Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses R Bos, L Rutten, JEM van der Lubbe, MJG Bakkers, G Hardenberg, ... npj Vaccines 5 (1), 91, 2020 | 341 | 2020 |
A highly stable prefusion RSV F vaccine derived from structural analysis of the fusion mechanism A Krarup, D Truan, P Furmanova-Hollenstein, L Bogaert, P Bouchier, ... Nature communications 6 (1), 8143, 2015 | 323 | 2015 |
Sequence and structure alignment of Paramyxoviridae attachment proteins and discovery of enzymatic activity for a morbillivirus hemagglutinin JP Langedijk, FJ Daus, JT Van Oirschot Journal of virology 71 (8), 6155-6167, 1997 | 190 | 1997 |
Molecular mechanism of respiratory syncytial virus fusion inhibitors MB Battles, JP Langedijk, P Furmanova-Hollenstein, ... Nature chemical biology 12 (2), 87-93, 2016 | 154 | 2016 |
Stabilizing the closed SARS-CoV-2 spike trimer J Juraszek, L Rutten, S Blokland, P Bouchier, R Voorzaat, T Ritschel, ... Nature communications 12 (1), 244, 2021 | 143 | 2021 |
Immunodominance and antigenic variation of the principal neutralization domain of HIV-1 G Zwart, H Langedijk, L Van Der Hoek, JJ De Jong, TFW Wolfs, ... Virology 181 (2), 481-489, 1991 | 130 | 1991 |
The principal neutralization determinant of simian immunodeficiency virus differs from that of human immunodeficiency virus type 1. K Javaherian, AJ Langlois, S Schmidt, M Kaufmann, N Cates, ... Proceedings of the National Academy of Sciences 89 (4), 1418-1422, 1992 | 127 | 1992 |
Vaccine-induced immunopathology during bovine respiratory syncytial virus infection: exploring the parameters of pathogenesis AFG Antonis, RS Schrijver, F Daus, PJGM Steverink, N Stockhofe, ... Journal of virology 77 (22), 12067-12073, 2003 | 119 | 2003 |
Structural and functional relationship between the receptor recognition and neuraminidase activities of the Newcastle disease virus hemagglutinin-neuraminidase protein … RM Iorio, GM Field, JM Sauvron, AM Mirza, R Deng, PJ Mahon, ... Journal of virology 75 (4), 1918-1927, 2001 | 114 | 2001 |
Proposed three-dimensional model for the attachment protein G of respiratory syncytial virus JPM Langedijk, WMM Schaaper, RH Meloen, JT van Oirschot Journal of General Virology 77 (6), 1249-1257, 1996 | 106 | 1996 |
Measles virus (MV) hemagglutinin: evidence that attachment sites for MV receptors SLAM and CD46 overlap on the globular head N Massé, M Ainouze, B Néel, TF Wild, R Buckland, JPM Langedijk Journal of virology 78 (17), 9051-9063, 2004 | 105 | 2004 |
Immunization of cattle with a BHV1 vector vaccine or a DNA vaccine both coding for the G protein of BRSV RS Schrijver, JPM Langedijk, GM Keil, WGJ Middel, M Maris-Veldhuis, ... Vaccine 15 (17-18), 1908-1916, 1997 | 102 | 1997 |
The Attachment Protein of Hendra Virus Has High Structural Similarity but Limited Primary Sequence Homology Compared with Viruses in the GenusParamyxovirus M Yu, E Hansson, JPM Langedijk, BT Eaton, LF Wang Virology 251 (2), 227-233, 1998 | 90 | 1998 |
Detailed mechanistic insights into HIV-1 sensitivity to three generations of fusion inhibitors D Eggink, JPM Langedijk, AMJJ Bonvin, Y Deng, M Lu, B Berkhout, ... Journal of biological chemistry 284 (39), 26941-26950, 2009 | 88 | 2009 |
Selection of T1249-resistant human immunodeficiency virus type 1 variants D Eggink, CE Baldwin, Y Deng, JPM Langedijk, M Lu, RW Sanders, ... Journal of virology 82 (13), 6678-6688, 2008 | 88 | 2008 |
Phase 1 safety and immunogenicity study of a respiratory syncytial virus vaccine with an adenovirus 26 vector encoding prefusion F (Ad26. RSV. preF) in adults aged≥ 60 years K Williams, AR Bastian, RA Feldman, E Omoruyi, E de Paepe, J Hendriks, ... The Journal of infectious diseases 222 (6), 979-988, 2020 | 87 | 2020 |
A gp41 MPER-specific llama VHH requires a hydrophobic CDR3 for neutralization but not for antigen recognition D Lutje Hulsik, Y Liu, NM Strokappe, S Battella, M El Khattabi, LE McCoy, ... PLoS pathogens 9 (3), e1003202, 2013 | 85 | 2013 |